The induction of KNG1, KLK1, and BDKRB2 in primary nasal samples of SARS-CoV-2-positive study participants is evidence for an autocrine bradykinin effect via B2R that is triggered locally during COVID-19 disease. Here, BDKRB2 is linked to COVID-19.